156 related articles for article (PubMed ID: 12763214)
1. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
[TBL] [Abstract][Full Text] [Related]
2. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
[TBL] [Abstract][Full Text] [Related]
3. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
[TBL] [Abstract][Full Text] [Related]
4. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
[TBL] [Abstract][Full Text] [Related]
5. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.
Blazeby JM; Fayers P; Conroy T; Sezer O; Ramage J; Rees M;
Br J Surg; 2009 Mar; 96(3):291-8. PubMed ID: 19224519
[TBL] [Abstract][Full Text] [Related]
6. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
7. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
8. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
9. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Sprangers MA; te Velde A; Aaronson NK
Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
[TBL] [Abstract][Full Text] [Related]
10. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
[TBL] [Abstract][Full Text] [Related]
11. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
[TBL] [Abstract][Full Text] [Related]
12. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
13. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
[TBL] [Abstract][Full Text] [Related]
14. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
Vickery CW; Blazeby JM; Conroy T; Johnson CD; Alderson D
Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718972
[TBL] [Abstract][Full Text] [Related]
15. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
Blazeby JM; Alderson D; Winstone K; Steyn R; Hammerlid E; Arraras J; Farndon JR
Eur J Cancer; 1996 Oct; 32A(11):1912-7. PubMed ID: 8943674
[TBL] [Abstract][Full Text] [Related]
16. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
17. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
[TBL] [Abstract][Full Text] [Related]
18. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group.
Sprangers MA; Cull A; Groenvold M; Bjordal K; Blazeby J; Aaronson NK
Qual Life Res; 1998 May; 7(4):291-300. PubMed ID: 9610213
[TBL] [Abstract][Full Text] [Related]
19. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Stead ML; Brown JM; Velikova G; Kaasa S; Wisløff F; Child JA; Hippe E; Hjorth M; Sezer O; Selby P
Br J Haematol; 1999 Mar; 104(3):605-11. PubMed ID: 10086801
[TBL] [Abstract][Full Text] [Related]
20. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report.
Cull A; Howat S; Greimel E; Waldenstrom AC; Arraras J; Kudelka A; Chauvenet L; Gould A; ;
Eur J Cancer; 2001 Jan; 37(1):47-53. PubMed ID: 11165129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
